A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving the Hands and/or Feet
NCT00312026
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
75
Enrollment
INDUSTRY
Sponsor class
Conditions
Psoriasis
Interventions
DRUG:
efalizumab
Sponsor
Genentech, Inc.